European Medicines Agency tightens rules on conflict of interestBMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c5902 (Published 19 October 2010) Cite this as: BMJ 2010;341:c5902
- Deborah Cohen
The European Medicines Agency has launched much stricter rules for its experts’ interaction with the drug industry.
The agency’s new guidance on conflicts of interest says that people who have financial interests in a company or who consult or are a member of a company’s advisory board will have their work with the agency severely restricted.
People will be asked to fill in a declaration of interests form and will be assigned a “risk” score that is based on their links with industry. The agency will also consider whether an expert’s institution receives money from a company or whether the expert is an investigator on …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial